Announcement • 10h
Perimeter Medical Imaging AI, Inc. to Report Q1, 2026 Results on May 28, 2026 Perimeter Medical Imaging AI, Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 28, 2026 Announcement • Apr 22
Perimeter Medical Imaging AI, Inc. announced that it expects to receive CAD 14.34655 million in funding from SC Master Holdings, LLC Perimeter Medical Imaging AI, Inc. announces that it has entered into an agreement with Paradigm Capital Inc., as lead agent in connection with a best efforts to issue 21,489,000 units of the Company at a price of CAD 0.35 per unit for gross proceeds of CAD 7,521,150 and a concurrent non-brokered private placement of convertible debentures (the "Convertible Debentures"), for aggregate gross proceeds of up to approximately CAD 6,825,400(1USD = CAD 1.365080) for aggregate proceeds of CAD 14,346,550 on April 21, 2026. Each Unit will be comprised of one common share in the capital of the Company and one Common Share purchase warrant. Each Warrant shall entitle the holder to acquire one Common Share for a period of 60 months from the closing of the LIFE Offering, at an exercise price of CAD 0.50. the Company has entered into binding subscription agreements with Adrian Mendes, its Chief Executive Officer, and Returning investor SC Master Holdings LLC. Under the Concurrent Offering, each Convertible Debenture will consist of $1,000 principal amount of 3.59% convertible debentures of the Company, maturing three years following the initial closing date of the Concurrent Offering. The outstanding principal under the Convertible Debentures will be convertible at the option of the holder, at any time prior to the close of business on the last business day immediately preceding the Maturity Date, into units of the Company at the conversion price of CAD 0.415 per Debenture Unit. All securities issued pursuant to the LIFE Offering will not be subject to a hold period under applicable Canadian securities laws. All securities issued pursuant to the Concurrent Offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable Canadian securities laws. The first tranche of the LIFE Offering is expected to close on or about May 5, 2026 (the "Closing Date") and the first tranche of the Concurrent Offering is expected to close on or about April 24, 2026, both of which are subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the TSX Venture Exchange. Breakeven Date Change • Apr 07
No longer forecast to breakeven The 3 analysts covering Perimeter Medical Imaging AI no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of US$3.13m in 2028. New consensus forecast suggests the company will make a loss of US$19.2m in 2028. 
